Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MTFMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GNB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DFFA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BIRC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAP1GDS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS10-NUDT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NEIL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC5A12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGSF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SEPHS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLEU1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RABEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM104B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DANCR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERGIC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on